Elliott Wave Analysis: S&P500 Intraday View


E-mini S&P500 turned up last week from 2248 where recent decline found a support after three subwaves down. This is a structure of a corrective price, maybe of a big triangle that may send prices higher after another short-term pullback down to 2260-2263 area, where broken channel line can turn into a support.

EW-Forecast.com has a special offer available on yearly membership, with 31% OFF.

Visite http://www.ew-forecast.com/service for details

S&P500, 1H

Elliott Wave Analysis: GOLD Could Face A Temporary Correction


Gold is trading nicely bullish for the last month with clean five waves up from 1120 area, which means a temporary correction could be just around the corner. That said we expect to see a new three wave of retracement in wave 2 to around the 1171-1177 level to unfold, before bulls can again resume.

EW-Forecast.com has a special offer available on yearly membership, with 31% OFF.

Visite http://www.ew-forecast.com/service for details


INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) Continues to Progress with Cannabinoid Research


INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) shares were up 26.65% on Friday to $0.238 and flat in after-hours trading. The company has a market cap of $9.94 million at 52.88 million shares outstanding. Share prices have been trading in a 52-week range of $0.05 to $0.26 so prices are approaching the resistance.

INMED PHARMACEUTIC COM NPV CEO Eric Adams recently talked about the cannabis plant’s enormous potential for new therapies in the pharmaceutical industry during his interview with BNN. In this interview, he highlighted the company’s R&D pipeline targeting serious medical conditions like Epidermolysis Bullosa and glaucoma. Aside from these diseases, the company also shared that it was progressing on the R&D program for cannabinoids use in treatment of chronic obstructive pulmonary disease or COPD.

For Chief Scientific Officer of INMED PHARMACEUTIC COM NPV Dr. Sazzad Hossain,  the preliminary data holds significance because of the role of cannabinoid-based therapies in treating COPD since cannabinoids were capable of releasing anti-inflammatory properties along with bronchodilatory and immunosuppressive characteristics. The company plans to validate its proprietary bioinformatics analysis tool to identify drug-disease targets and use them in the pre-clinical models for treatment.

Soon after, INMED PHARMACEUTIC COM NPV announced the appointment of Martin Bott, VP of Corporate Finance and Investment Banking at Eli Lilly & Company, to the Board of Directors.

“Martin Bott has established a significant leadership position in financial and business expertise with one of the world’s leading pharmaceutical companies. His depth of knowledge in navigating the complexities in healthcare finance and operations on a global level will be invaluable to InMed,” said Eric Adams, President and CEO of INMED PHARMACEUTIC COM NPV . “We welcome Martin to our Board and look forward to his strategic counsel as we work towards achieving our many corporate objectives.”

Bott brings over 28 years of senior financial and executive leadership, after having held roles of increasing responsibility at their headquarters in Indianapolis since joining Eli Lilly & Company in 1988.

“I am delighted to be joining InMed as a Board Member,” stated Bott. “InMed is at a pivotal point in its evolution.  Its broad base of assets, from the drug development pipeline to the cannabinoid biosynthesis and other enabling technologies, will require careful planning and execution. I look forward to working with the other Directors and executive team to contributing to the achievement of InMed’s strategic initiatives and future growth.”

INMED PHARMACEUTIC COM NPV is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The company uses its proprietary bioinformatics assessment tool to identify bioactive compounds within the cannabis plant that have the potential to have physiological impacts on specific diseases.

It aims to identify new drug candidates that optimize therapeutic benefit while limiting adverse effects. Its proprietary in silico drug or disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the company.

New Colombia Resources Inc (OTCMKTS:NEWC) to Supply Coal to China


New Colombia Resources Inc (OTCMKTS:NEWC) shares could be poised for tremendous upside although prices were flat on Friday at $0.0280. The company has a market cap of $4.32 million at 154.34 million shares outstanding.Share prices have been trading in a 52-week range of $0.00 to $0.05.

At the start of the year, New Columbia Resources Inc signed a $90 million purchase agreement for metallurgical coal with American Steel Industries of Philadelphia under a joint venture with a Chinese government-owned giant in the commodities and steel trading segment. This company has  been exporting steel from China for the past 12 years and is one of its largest steel exporters.

Under the terms of the contract, some of the coal will be supplied by the joint venture’s Mina San Gregorio in Cucuta, Colombia while the remainder will be sourced from third-party producers then stored at New Columbia Resources Inc’s coal yard in Cucuta with a 50,000 ton capacity and industrial scale, then trucked or barged to a port on the Caribbean coast for shipment to South China. This could mean significant revenue potential for the company, especially since metallurgical coal has seen a bullish wave since last year on rising demand and increasing orders.

New Columbia Resources Inc is also delving into the cannabis industry, which analysts also dubbed as the next growth sector for the next few years. After all, the November 8 vote to legalize the use of medical or recreational marijuana in several US states could bring the market up to $20 billion by 2020.

The company recently announced that it is developing a portfolio of medical marijuana products, and intends to submit an Orphan Drug application to the FDA in the US through a partnership with Advanced Imaging Projects LLC. It has reserved a spot in the USA Today’s 2017 Special Edition Colorado Rockies Preview to advertise Sannabis’ SANNAXHOL Pain Cream topical product made of cannabis sativa flower and other all natural ingredients native to Colombia. This product has been tested by a licensed medical marijuana testing facility in the U.S. and shown to have minimal traces of THC, which can be imported and sold in the country.

New Columbia Resources Inc is a metallurgical coal company that is engaged in the acquisition and development of high quality metallurgical coal producers in Colombia. It is focusing on its La Tabaquera coal and rock project located in the Municipality of Guaduas, approximately 100 kilometers northwest of Bogota.

The 57 hectares La Tabaquera and the 390 hectares mine La Herradura, are located to the west of the La Bermeja Ravine, crossing Rio Guaduero from north to south, with a linear extension of 2.5 kilometers north-south direction and 0.2 kilometers approximately from east-west. Its rock crushing plant has a processing capacity of over 100 cubic meters per hour of aggregates. It also has a medical cannabis business in Colombia operating as Sannabis SAS.

Bulls Charging on OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Stock


OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) shares were up 35.44% on Friday and flat in after-hours trading at $0.535. The company has a market cap of $77.44 million at 135.31 million shares outstanding. Share prices have been trading in a 52-week range of $0.00 to $0.55.

OWC Pharmaceutical Research Corp is a medical cannabis research and development company that is engaged in the research and development of cannabis-based medical products for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications.

Aside from that, it also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. It works with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder migraines and a delivery system.

What sets OWC Pharmaceutical Research Corp apart from its competitors in the medical marijuana industry is that it conducts its R&D primarily in Israel, which is considered one of the best places in the world for cannabis research. “Unlike the U.S. government, the Israeli government has had few restrictions on doing research on cannabis, whether basic science or clinical studies,” noted an article on The Cannabist.

With that, OWC Pharmaceutical Research Corp is able to leverage its research division to tap the extensive network comprising some of Israel’s leading researchers, scientists, universities and hospitals, as well as cannabis breeders and extractors. Through this, they are able to study and test the effectiveness of different combinations of cannabinoids in the treatment of disease and chronic conditions with fewer restrictions.

The company has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. It has also signed a Memorandum of Understanding with Emilia Cosmetics Ltd., a large Israeli private label manufacturer, for the development, manufacture and marketing of a cannabinoid-based topical cream to treat psoriasis.

Last year, OWC Pharmaceutical Research Corp completed the development of a proprietary, cannabinoid-enriched sublingual tablet for the administration of medical cannabis. This tablet provides for the ingestion of virtually any dosage of medical cannabis with a sublingual delivery mechanism, whereby the compounds are absorbed directly into the patient’s blood through oral epithelial tissue. It also enables physicians to safely and accurately monitor the dosage and treatment of each individual patient, and the company is working to have this approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use in the country.

In November, OWC Pharmaceutical Research Corp gained access to additional financing. It filed a Form 8-K reporting that it had entered into a Reg S Unit Subscription Agreement with Michepro Holding Ltd, organized under the laws of Cyprus in which the investorsubscribed for and purchased the company’s securities for cash consideration of $300,000.

Additional Volatility on Ubiquitech Software Corp (OTCMKTS:UBQU) Shares


Ubiquitech Software Corp (OTCMKTS:UBQU) shares popped up 3.70% on Thursday to $0.0168 then retreated 4.46% in after-hours trading to $0.0160. Share prices have been trading in a 52-week range of $0.01 to $0.06. The company has a market cap of $1.73 million at 94.71 million shares outstanding.

Earlier this week, Ubiquitech Software Corp announced its plans to change the company name to Endo Biosciences in order to reflect its shifting focus and to allow more ventures to be included in its strategy down the line. Yesterday, the company shared that it concluded negotiations and reached an agreement to expand its hemp growing capabilities through an additional 140 acres of available hemp operations.

This greatly supports its main subsidiary HempLife Today, which is poised for strong growth now that several US states have approved the use of medical or recreational marijuana. Analysts project that the market will grow to $7.1 billion this year and to $20 billion by 2020.

“With all that we have learned and achieved in 2016 we really look at 2017 as our first solid year for consistent and substantial growth,” remarkedJames Ballas, CEO of Ubiquitech Software Corp. “And we’ve hit the ground running at a much higher capacity right from the start. This should make first quarter our best ever, and everything we do is to create growth throughout the year.”

“With our new agreement on expansion we will have no problem meeting the demand for our CannazALL products,” added Tim Zorn, President of Ubiquitech Software Corp. “With continued month over month growth that we are planning for it’s great to know that we can always fulfill orders, and also be introducing new products to the market.”

The company’s latest developments ensure that it can meet expected demand over the next five years without interruption. After all, the CBD-rich products that it produces are 100% Federally legal hemp strains that are registered with the Colorado State Department of Agriculture and conform fully with the 2014 US Farm Bill section 7606.

Ubiquitech Software Corp is a company that was previously engaged in the sale of dual subscriber identity module, dual-telephone-number mobile phone solutions with no contract, pre-paid unlimited text and voice. The dual SIM feature allows the consumer to have two telephone numbers ring to a single phone.

Through its subsidiary, Blue Crush Marketing Group (BCMG), the company also markets a Blue Crush Monetization System, which consists of Internet technologies along with other online advertising methods. BCMG also offers Blue Crush Connect, a social media portal that connects its customers to its Websites, brands and offers. Another subsidiary called Hemp Life Today offers CannazALL, a canabidiol oil made from domestically grown hemp. Ubiquitech Software Corp is also engaged in the development of FusionFundraiser, a mobile application to allow traditional fundraisers for schools, clubs, organizations, sports teams and others to access a mobile application.

Time to Buy Wanderport Corp (OTCMKTS:WDRP) Shares on Dips?


Wanderport Corp (OTCMKTS:WDRP) shares fell 22.45% to $0.00380 on Thursday and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.01. The company has a market cap of $3.20 million at 686.50 million shares outstanding.

Wanderport Corp announced this week that it continues to receive positive and encouraging feedback on taste and quality of its Sapa Coffee. It isnow maintaining a readily available inventory to meet demand, and has strategized to introduce two enticing new hemp coffee flavors set to be unveiled next month including a premium decaf blend while it receives a growing number of reorders.

On top of its current line of hemp blends, Wanderport Corp plans on introducing a specialty CBD line with two tasty flavors by February. It also has plans to collaborate  with licensed business partners to introduce a line of THC infused coffee. Lastly, it also plans to market and sell a select line of its coffee along with other products on Amazon and other market places once has been able to fulfill the necessary requirements.

“Seeking to deliver an enhanced coffee drinking experience, we continue to explore blends that will yield the delicious bold, smooth and balanced flavors that will energize the daily routine with an enjoyable boost and fueling busy lifestyles of our growing number of enthusiasts.” stated Anna Seidman, CEO of Wanderport Corporation. “We are excited to add four new blends to our existing line and are confident that they will be very well received.”

Wanderport Corp is a development-stage company that distributes food, beverages and consumer products made with hemp. Among these products are Sapa Coffee, Cannabissimo Coffee, CBD Nectars, DuBe Energy Shot, and Cannabios and Trompetol Body Care.

Sapa Coffee are coffee beans sourced from Central and South America, grounded and blended with roasted hemp hearts. Cannabissimo Coffee is a flavored blend of hemp seeds and roasted ground coffee beans. The CBD Nectars offering includes vape liquids, oil and tinctures. DuBe Energy Shot is a hemp infused energy shot. Cannabios includes cannabinoid-based body care products on the market. The Cannabios line consists of balm, shampoo, shower gel, massage oil, sun screen and baby lotions enriched with hemp-derived cannabidiol. Trompetol lotions and skin care creams offer a serum without any artificial coloring, dyes or toxic perfumes. Trompetol EXTRA is designed to address muscle and joint issues.

What’s In Store for UA Multimedia Inc (OTCMKTS:UAMM) This 2017?


UA Multimedia Inc (OTCMKTS:UAMM) shares advanced 14.29% on Thursday to $0.00160 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.00. The company has 60.75 million shares outstanding.

In a press release yesterday, UA Multimedia Inc issued an update for shareholders onon recent advancements, and how its emerging vision and corporate strategies continue to develop in anticipation of substantially increasing demands in the evolving cannabis marketplace.

“Management is pleased to reveal the introduction of a turn-key modular indoor growing station, equipped with state-of-the-art lighting and an efficient nutrient delivery system.  The station will be made in USA, and can be utilized for growing organic vegetables or medicinal cannabis.  The system is expected to be available for purchase by the end of this quarter,” the report indicated.

The company shifted its focus to the cannabis industry right around the successful November 8 vote, which legalized the use of medical or recreational marijuana in several US states. This led analysts to project that the market could swell to $20 billion by 2020 and to $7.1 billion this year. UA Multimedia Inc expects to launch their cannabis segment with significant momentum and rake in revenues in the short-term.

It has already been able to generate interest in California and has initiated the necessary filing updates with OTC Markets. UA Multimedia Inc has plans to restructure in order to accurately reflect their new evolving core business model and support successful branding efforts, developing a strategy that will enable them to conduct business in a variety of sectors. As part of this reorganization, the company plans to optimize the capital structure through the retirement of stock.

“We are excited about the recent industry development and our Companys prospect for 2017. Our goal is to successfully position the Company to capitalize on the burgeoning cannabis industry by offering practical and high demand products.” stated Thu Pham, Chief Executive Officer of UA Multimedia Inc. “We are actively executing the new business model and as advancement is realized, our shareholders will be promptly updated.”

UA Multimedia Inc is a former media company that has entered the cannabis industry with the anticipated launch of its turn-key modular indoor growing systems. The company also plans to introduce a range of cannabis based products and dietary supplements in the near future.

Elliott Wave Analysis: S&P500 Intraday View


E-mini S&P500 moved down to 2250-2255 area yesterday, where market found a support as expected after wave c down which might already completed a corrective price action based on recent bounce to 2270. We however still need break above upper channel resistance line to confirm a new leg up, towards 2290/2300.




S&P500, 1H


Don’t Miss This Surge on Uranium Resources Inc (NASDAQ:URRE) Shares!


Uranium Resources Inc (NASDAQ:URRE) shares jumped 41.78% to $3.19 and an additional 5.64% in after-hours trading to $3.37. The company has a market cap of $54.89 million at 13.38 million shares outstanding. Share prices have been trading in a 52-week range of $0.97 to $6.00.

Last week, Uranium Resources Inc announced that it as closed the sale of its Churchrock and Crownpoint properties in New Mexico to Laramide Resources Ltd. at $12.5M comprised of $2.5 million cash, $500,000 of LAM common stock and warrants, a promissory note in the amount of $5.0 million, half of which LAM may satisfy through issuance of its common stock, and a retained NSR royalty on the Properties valued at $4.5 million.

“The sale of our Churchrock and Crownpoint properties to Laramide represents URI’s third asset monetization transaction in the last three years. We remain focused on improving the alignment of our uranium portfolio with our production experience and expertise in in-situ recovery of uranium, targeting uranium operations that fit into the lowest quartile of operating costs.  We will use the proceeds received from this sale to fund the expansion of our energy metals strategy, which includes developing our new lithium business, while maintaining optionality on the future rising uranium price,” noted Uranium Resources Inc President and CEO Christopher Jones.

Following this announcement, uranium prices jumped in the global market when top producer Kazakhstan declared that they will slash output by 10% this year due to poor market conditions. This would significantly put a dent on supply, thereby leading to higher prices.

“These strategic [uranium] assets are far more valuable to our shareholders and stakeholders being left in the ground for the time being, rather than adding to the current oversupply situation,” Kazatomprom Chairman Askar Zhumagaliyev said in the statement. Kazatomprom is a state-owned uranium company. According to analysts, this reduction in output could represent a significant floor for the commodity and that price could continue to climb in the near term.

Uranium Resources Inc is a uranium exploration, development and production company. It has approximately 190,000 acres of mineral holdings in the prolific Grants Mineral Belt of the State of New Mexico and approximately 14,000 acres in the South Texas uranium province. Its uranium exploration and development activities are focused principally in the United States and the Republic of Turkey.

In particular, Uranium Resources Inc properties include Temrezli Project, Kingsville Dome Project, Rosita Project, Vasquez Project, Butler Ranch Project, Churchrock Project, Crownpoint Project, Cebolleta Project and Juan Tafoya Project. The Kingsville Dome property is located in Kleberg County. The Juan Tafoya Project is located approximately 45 miles west-northwest of Albuquerque. The Cebolleta project is located in west-central New Mexico. The Sejita Dome exploration project is located in southern Duval County, Texas. The Vasquez project is located in southwestern Duval County, Texas.

More Upside Potential for Zerez Holdings Inc (OTCMKTS:ZRZH) Shares?


Zerez Holdings Inc (OTCMKTS:ZRZH) shares were up 29.09% to $0.0213 on Wednesday and flat in after-hours trading. The company has a market cap of $5.2 million. Share prices have been trading in a 52-week range of $0.00 to $0.05.

In a recent press release, Zerez Holdings Inc announced it has signed a strategic co-marketing and sales agreement with Sweet Leaf Hydroponics for its subsidiary Next Generation Farming Inc’s smart greenhouse technology. The deal is valued at over one million in Northern California revenues for fiscal year 2017.

“This agreement with Sweet Leaf Hydro is strategic to both companies’ growth in the explosive organic farming and cannabis marketplace. Our advanced automated greenhouse line of products, proprietary automation systems and various accessories needs key strategic partners to fully implement our business plan to dominate the west coast in brand recognition. As a result, we sought out Jay DeSalvatore, and Sweet Leaf Hydroponics, the most capable, most reputable company in the California Central Valley to work with us. They have a proven track record of turnkey sales capabilities that services thousands of clients and annual revenues of several million dollars. That stability and customer loyalty is exactly the kind of partner we want to help us expand our business and maintain the quality standards that we have set for our company,” explained Zerez Holdings Inc President John Taylor.

This was followed by news that the company has completed delivery of another advanced turnkey greenhouse system to a Northern California client. The facility will be used for both organic farming and legal cannabis cultivation and the deal was valued at $181,000. Vice President Don Smith mentioned that Zerez Holdings Inc continues to gain awareness each time they are able to demonstrate their performance with brick and mortar facilities, hinting that further greenhouse systems might be in the works.

“We are very excited that we have completed our next sale. We continue to refine and streamline our internal processes with each installation which will decrease overall project timelines, and improve profitability through efficiency. One of the keys to our early success is consistent communication with our clients and with our various manufacturers. This gives our crew and the customer a predictable timeline, which on a large turnkey project is critical to getting operational and generating return on the client’s investment as soon as possible,” remarked Taylor.

According to its About page, Zerez Holdings Inc is a company comprised of business professionals with a focus on the future of business, by providing information and services that offer alternative strategies for every business sector, offering liquidity through asset based infrastructure and senior level support. Its team of experts serve each client through comprehensive strategies designed to incorporate a multitude of business platforms and sectors,  allowing the client to maintain ongoing operations by securing growth capital through the incubation period, designed to maintain a strong presence in their specific market sectors. This process is enhanced by several initiatives secured as subsidiaries of a parent company.

Elliott Wave Analysis: EURUSD Trading Lower Within An Impulse


EURUSD is turning sharply lower from the 1.1300 level where pair have finally accomplished a big and very long sideways pattern that was located in wave IV. It was a triangle which is now completed. A decisive break beneath the wave B swing at 1.0533 level was a confirmation for a completed higher degree correction and that more weakness may be in progress. That said, the updated wave count is showing us the pair trading in red sub-wave 4) of three, that may in days ahead see more slow and choppy price activity.